Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers

Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers

The aim of this study was to determine clinical value of alone and combined use of serum cytokeratin (CK)-18, carcinoembryonic antigen (CEA) and CA 19-9 in esophageal squamous cell carcinoma and gastric adenocarcinoma. Serum tumor markers were measured in 60 patients who had esophageal squamous cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eastern journal of medicine 2004-07, Vol.9 (2), p.72
Hauptverfasser: Tuncer, Ilyas, Dülger, Haluk, Uygan, Ismail, Öztürk, Mustafa, Kotan, Çetin, Sekeroglu, Ramazan
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Cancer
Clinical medicine
Mortality
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 72
container_title Eastern journal of medicine
container_volume 9
creator Tuncer, Ilyas
Dülger, Haluk
Uygan, Ismail
Öztürk, Mustafa
Kotan, Çetin
Sekeroglu, Ramazan
description The aim of this study was to determine clinical value of alone and combined use of serum cytokeratin (CK)-18, carcinoembryonic antigen (CEA) and CA 19-9 in esophageal squamous cell carcinoma and gastric adenocarcinoma. Serum tumor markers were measured in 60 patients who had esophageal squamous cell carcinoma or gastric adenocarcinoma. Thirty healthy subjects served as controls. In patients with gastric adecarcinoma serum CK-18 levels were significantly increased compared to both esophageal squamus cell carcinoma and control groups (p0.05). The sensitivity of serum CK-18, CEA and CA19- 9 in esophageal squamous cell carcinoma were 53%, 70% and 66%, respectively. For gastric adenocarcinoma, the sensitivity of each tumor marker was similar 70%, 70% and 70%, respectively. CK-18/CA19-9 combination in the esophageal (83%) and gastric carcinomas (93%) were found to be more sensitive than other tumor markers when these markers were evaluated in combination. CEA exhibited the highest sensitivity for esophageal squamous cell carcinoma compared to CK-18, and CA19-9. However, the sensitivity of all tumor markers in gastric adenocarcinoma were similar. The combination of CK-18 and CA19-9 could increase the diagnostic sensitivity in esophageal and gastric carcinomas. [PUBLICATION ABSTRACT]
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_757815568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2162040001</sourcerecordid><originalsourceid>FETCH-proquest_journals_7578155683</originalsourceid><addsrcrecordid>eNqNiksKwjAUAIMo-L3Dw7WBxtr2dSlB8QAuhRLqU1vbpOalgrdXxAO4moGZgZioOMpljJgOv65khBiPxZS5jqI14kZNxEm7tjO-YmfBXYDJ9y2Ur-Du5E2orFS4Ar3bgrFn0FtQucyhoSc1DJUFYtfdzJVM8x2uhoOvSiiNLcnzXIwupmFa_DgTy_3uqA-y8-7RE4eidr23n1RkSYYqSVKM_5reII9CIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>757815568</pqid></control><display><type>article</type><title>Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tuncer, Ilyas ; Dülger, Haluk ; Uygan, Ismail ; Öztürk, Mustafa ; Kotan, Çetin ; Sekeroglu, Ramazan</creator><creatorcontrib>Tuncer, Ilyas ; Dülger, Haluk ; Uygan, Ismail ; Öztürk, Mustafa ; Kotan, Çetin ; Sekeroglu, Ramazan</creatorcontrib><description>The aim of this study was to determine clinical value of alone and combined use of serum cytokeratin (CK)-18, carcinoembryonic antigen (CEA) and CA 19-9 in esophageal squamous cell carcinoma and gastric adenocarcinoma. Serum tumor markers were measured in 60 patients who had esophageal squamous cell carcinoma or gastric adenocarcinoma. Thirty healthy subjects served as controls. In patients with gastric adecarcinoma serum CK-18 levels were significantly increased compared to both esophageal squamus cell carcinoma and control groups (p&lt;0.01, p&lt;0,05 respectively). But there was no significant difference in CK-18 levels between esophageal squamous cell carcinoma patients and healthy subjects (p&gt;0.05). On the other hand, serum CEA and CA 19-9 levels did not differ between groups (p&gt;0.05). The sensitivity of serum CK-18, CEA and CA19- 9 in esophageal squamous cell carcinoma were 53%, 70% and 66%, respectively. For gastric adenocarcinoma, the sensitivity of each tumor marker was similar 70%, 70% and 70%, respectively. CK-18/CA19-9 combination in the esophageal (83%) and gastric carcinomas (93%) were found to be more sensitive than other tumor markers when these markers were evaluated in combination. CEA exhibited the highest sensitivity for esophageal squamous cell carcinoma compared to CK-18, and CA19-9. However, the sensitivity of all tumor markers in gastric adenocarcinoma were similar. The combination of CK-18 and CA19-9 could increase the diagnostic sensitivity in esophageal and gastric carcinomas. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 1301-0883</identifier><identifier>EISSN: 1309-3886</identifier><language>eng</language><publisher>Van: YYU Tip Fakultesi</publisher><subject>Biomarkers ; Cancer ; Clinical medicine ; Mortality ; Tumors</subject><ispartof>Eastern journal of medicine, 2004-07, Vol.9 (2), p.72</ispartof><rights>Copyright YYU Tip Fakultesi Jul-Dec 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Tuncer, Ilyas</creatorcontrib><creatorcontrib>Dülger, Haluk</creatorcontrib><creatorcontrib>Uygan, Ismail</creatorcontrib><creatorcontrib>Öztürk, Mustafa</creatorcontrib><creatorcontrib>Kotan, Çetin</creatorcontrib><creatorcontrib>Sekeroglu, Ramazan</creatorcontrib><title>Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers</title><title>Eastern journal of medicine</title><description>The aim of this study was to determine clinical value of alone and combined use of serum cytokeratin (CK)-18, carcinoembryonic antigen (CEA) and CA 19-9 in esophageal squamous cell carcinoma and gastric adenocarcinoma. Serum tumor markers were measured in 60 patients who had esophageal squamous cell carcinoma or gastric adenocarcinoma. Thirty healthy subjects served as controls. In patients with gastric adecarcinoma serum CK-18 levels were significantly increased compared to both esophageal squamus cell carcinoma and control groups (p&lt;0.01, p&lt;0,05 respectively). But there was no significant difference in CK-18 levels between esophageal squamous cell carcinoma patients and healthy subjects (p&gt;0.05). On the other hand, serum CEA and CA 19-9 levels did not differ between groups (p&gt;0.05). The sensitivity of serum CK-18, CEA and CA19- 9 in esophageal squamous cell carcinoma were 53%, 70% and 66%, respectively. For gastric adenocarcinoma, the sensitivity of each tumor marker was similar 70%, 70% and 70%, respectively. CK-18/CA19-9 combination in the esophageal (83%) and gastric carcinomas (93%) were found to be more sensitive than other tumor markers when these markers were evaluated in combination. CEA exhibited the highest sensitivity for esophageal squamous cell carcinoma compared to CK-18, and CA19-9. However, the sensitivity of all tumor markers in gastric adenocarcinoma were similar. The combination of CK-18 and CA19-9 could increase the diagnostic sensitivity in esophageal and gastric carcinomas. [PUBLICATION ABSTRACT]</description><subject>Biomarkers</subject><subject>Cancer</subject><subject>Clinical medicine</subject><subject>Mortality</subject><subject>Tumors</subject><issn>1301-0883</issn><issn>1309-3886</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNiksKwjAUAIMo-L3Dw7WBxtr2dSlB8QAuhRLqU1vbpOalgrdXxAO4moGZgZioOMpljJgOv65khBiPxZS5jqI14kZNxEm7tjO-YmfBXYDJ9y2Ur-Du5E2orFS4Ar3bgrFn0FtQucyhoSc1DJUFYtfdzJVM8x2uhoOvSiiNLcnzXIwupmFa_DgTy_3uqA-y8-7RE4eidr23n1RkSYYqSVKM_5reII9CIQ</recordid><startdate>20040701</startdate><enddate>20040701</enddate><creator>Tuncer, Ilyas</creator><creator>Dülger, Haluk</creator><creator>Uygan, Ismail</creator><creator>Öztürk, Mustafa</creator><creator>Kotan, Çetin</creator><creator>Sekeroglu, Ramazan</creator><general>YYU Tip Fakultesi</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20040701</creationdate><title>Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers</title><author>Tuncer, Ilyas ; Dülger, Haluk ; Uygan, Ismail ; Öztürk, Mustafa ; Kotan, Çetin ; Sekeroglu, Ramazan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_7578155683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biomarkers</topic><topic>Cancer</topic><topic>Clinical medicine</topic><topic>Mortality</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tuncer, Ilyas</creatorcontrib><creatorcontrib>Dülger, Haluk</creatorcontrib><creatorcontrib>Uygan, Ismail</creatorcontrib><creatorcontrib>Öztürk, Mustafa</creatorcontrib><creatorcontrib>Kotan, Çetin</creatorcontrib><creatorcontrib>Sekeroglu, Ramazan</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Eastern journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tuncer, Ilyas</au><au>Dülger, Haluk</au><au>Uygan, Ismail</au><au>Öztürk, Mustafa</au><au>Kotan, Çetin</au><au>Sekeroglu, Ramazan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers</atitle><jtitle>Eastern journal of medicine</jtitle><date>2004-07-01</date><risdate>2004</risdate><volume>9</volume><issue>2</issue><spage>72</spage><pages>72-</pages><issn>1301-0883</issn><eissn>1309-3886</eissn><abstract>The aim of this study was to determine clinical value of alone and combined use of serum cytokeratin (CK)-18, carcinoembryonic antigen (CEA) and CA 19-9 in esophageal squamous cell carcinoma and gastric adenocarcinoma. Serum tumor markers were measured in 60 patients who had esophageal squamous cell carcinoma or gastric adenocarcinoma. Thirty healthy subjects served as controls. In patients with gastric adecarcinoma serum CK-18 levels were significantly increased compared to both esophageal squamus cell carcinoma and control groups (p&lt;0.01, p&lt;0,05 respectively). But there was no significant difference in CK-18 levels between esophageal squamous cell carcinoma patients and healthy subjects (p&gt;0.05). On the other hand, serum CEA and CA 19-9 levels did not differ between groups (p&gt;0.05). The sensitivity of serum CK-18, CEA and CA19- 9 in esophageal squamous cell carcinoma were 53%, 70% and 66%, respectively. For gastric adenocarcinoma, the sensitivity of each tumor marker was similar 70%, 70% and 70%, respectively. CK-18/CA19-9 combination in the esophageal (83%) and gastric carcinomas (93%) were found to be more sensitive than other tumor markers when these markers were evaluated in combination. CEA exhibited the highest sensitivity for esophageal squamous cell carcinoma compared to CK-18, and CA19-9. However, the sensitivity of all tumor markers in gastric adenocarcinoma were similar. The combination of CK-18 and CA19-9 could increase the diagnostic sensitivity in esophageal and gastric carcinomas. [PUBLICATION ABSTRACT]</abstract><cop>Van</cop><pub>YYU Tip Fakultesi</pub></addata></record>
fulltext fulltext
identifier ISSN: 1301-0883
ispartof Eastern journal of medicine, 2004-07, Vol.9 (2), p.72
issn 1301-0883
1309-3886
language eng
recordid cdi_proquest_journals_757815568
source EZB-FREE-00999 freely available EZB journals
subjects Biomarkers
Cancer
Clinical medicine
Mortality
Tumors
title Comparison of serum cytokeratin-18, CEA and CA 19-9 levels in esophageal and gastric cancers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A12%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20serum%20cytokeratin-18,%20CEA%20and%20CA%2019-9%20levels%20in%20esophageal%20and%20gastric%20cancers&rft.jtitle=Eastern%20journal%20of%20medicine&rft.au=Tuncer,%20Ilyas&rft.date=2004-07-01&rft.volume=9&rft.issue=2&rft.spage=72&rft.pages=72-&rft.issn=1301-0883&rft.eissn=1309-3886&rft_id=info:doi/&rft_dat=%3Cproquest%3E2162040001%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=757815568&rft_id=info:pmid/&rfr_iscdi=true